Photos: SOS Children's Villages Observes World Orphan Week, October ...(e public is invited to watch the 15 fina...),Health
Navigation Links
| HOME >> MEDICINE >> TECHNOLOGY |
Photos: SOS Children's Villages Observes World Orphan Week, October 5-11, 2008
Date:10/9/2008
e public is invited to watch the 15 finalist videos and vote for their favorite at http://www.sos-usa.org/vote.
About SOS Children's Villages
In existence since 1949, SOS Children's Villages is dedicated to the long-term care of orphaned and abandoned children. SOS offers a family-based model of care essential for the successful transition from childhood into adulthood. SOS Children's Villages has been nominated for the Nobel Peace Prize 14 times and has received the Conrad N. Hilton Humanitarian Prize. For more information please visit http://www.sos-usa.org.
Available Topic Expert(s): For information on the listed expert(s), click appropriate link.
Heather Paul
http://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=53513
'/>"/>
| SOURCE SOS Children's Villages Copyright©2008 PR Newswire. All rights reserved |
Related medicine technology :
1. Photos: NIH Launches New Web Site for Parents on Medical Research Studies for Children
2. Photos: Sentara Joins 4 U.S. Hospitals in International TARGIT Breast Cancer Trial
3. BioNumerik Pharmaceuticals Observes Evidence of a Survival Increase in Lung Cancer Patients Participating in Tavocept(TM) Clinical Trial
4. In celebration of World Hospice and Palliative Care Day, FHSSA Announces Seven New Partnerships Between U.S. Organizations and African Hospices
5. Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress
6. News Media Advisory: Worlds Leading Surgical Oncologists to Gather at McLaren Regional Medical Center to Present Latest Work on Breast, Gastrointestinal Cancer Treatments
7. Unprecedented 8th Year Start Up of National Direct AmeriCorps Program Access to Care Through Service (ACTS) Parent, Lead Organization The Philadelphia AIDS Consortium and World Health Care Infrastructures
8. ATL/TV1102 Trial Results Presented at World Congress on Treatment and Research in Multiple Sclerosis
9. Interleukin Genetics to Present Important New Findings at 2008 World Congress on Osteoarthritis
10. Senator Frist and Convention Delegates Support AIDS-Affected People Around the World, Raise Funds for Gustav Evacuees
11. Stem Cell Sciences Announces the Creation of the Worlds First Authentic Rat Embryonic Stem Cells from its Exclusively Licensed Technology
Post Your Comments:
(Date:12/1/2008)...y switch that, if turned off, causes lymphatic end...e their identity and become more like blood endoth...ewswire-USNewswire/ -- Scientists at St. Jude Chi...ertain differentiated cell type is so ready to cha...ression of a gene called Prox1 to dissuade it. ...
(Date:12/1/2008)...Call/ -- Genaera Corporation (Nasdaq: GENR ) to... study MSI-1436C-102 (Study 102), the multiple asc...436) in overweight and obese type 2 diabetics. MSI...type 2 diabetes and obesity which works centrally ...thways through the highly selective inhibition of ...
(Date:12/1/2008)...ber 9 at 11:00 am ET to Discuss Phase 2 Study Resu...if., Dec. 1 Sunesis Ph...ceutical company focused on the development and co...y announced new data from its studies of voreloxin... during the 50th American Society of Hematology (A...
(Date:12/1/2008)...al Incorporated (Nasdaq: VICL ) announced today ...om Merck & Co., Inc. based on Merck,s planned ...tigational plasmid DNA (pDNA) cancer vaccine. The ...ivery technology and encodes human telomerase reve... separate license agreement. , , "The bread...
Breaking Medicine Technology:Reprogrammable Cell Type Depends on a Single Gene to Keep Its Identity 2Reprogrammable Cell Type Depends on a Single Gene to Keep Its Identity 3Genaera Begins Phase 1b Trial of Trodusquemine (MSI-1436) in Overweight and Obese Type 2 Diabetics 2Genaera Begins Phase 1b Trial of Trodusquemine (MSI-1436) in Overweight and Obese Type 2 Diabetics 3Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia To Be Presented at ASH 2Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia To Be Presented at ASH 3Vical Receives Milestone Payment from Merck & Co., Inc. Triggered by Planned Initiation of Investigational Cancer DNA Vaccine Trial 2Vitamin D and breast cancer risk 17194 1Vitamin D and breast cancer risk 17194 2Study finds patients overestimate cancer screening history 17192 1Study finds patients overestimate cancer screening history 17192 2Woodland Park Care Center Earns Quality Respiratory Care Recognition 17190 1Woodland Park Care Center Earns Quality Respiratory Care Recognition 17190 2Huifeng Bio Pharmaceutical 28HFGB 29 Announces Participation in the 59th PHARMCHINA Expo 17188 1Huifeng Bio Pharmaceutical 28HFGB 29 Announces Participation in the 59th PHARMCHINA Expo 17188 2[0] Reprogrammable Cell Type Depends on a Single Gene to Keep Its Identity[0] Genaera Begins Phase 1b Trial of Trodusquemine (MSI-1436) in Overweight and Obese Type 2 Diabetics[0] Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia To Be Presented at ASH[0] Vical Receives Milestone Payment from Merck & Co., Inc. Triggered by Planned Initiation of Investigational Cancer DNA Vaccine Trial
...Professor Home said: , "The editorials published b...t they disregarded important pieces of data that,a...Most,significantly the editorials ignored data tha...ular death or death from any,cause." , Professor P...778-525-1736 , Terms and conditions of use apply ...
...ief within 5,minutes of dosing and is well-tolerat...arma Ltd,("Archimedes"), a European specialty phar...ata from a Phase II study of Nasalfent(r),an inno...ding a,fast, effective and convenient treatment fo... the 10th Congress of the European,Association for...
Other Medicine Technology:Archimedes Pharma Presents Positive Efficacy and Safety Data on,Nasalfent at European Association for Palliative Care Congress 2Archimedes Pharma Presents Positive Efficacy and Safety Data on,Nasalfent at European Association for Palliative Care Congress 3(Date:12/1/2008).../ -- Due to the urgent need to disseminate authori...ch and clinical care, publisher Mary Ann Liebert...ll archival online issues of the company,s AIDS jo...ld AIDS Day. Free online access is available for .../apc ) and AIDS Research and Human Retroviruses ...
(Date:12/1/2008)...Call/ -- Senetek PLC,(OTC Bulletin Board: SNKTY),...nt of technologies that target the science of heal..., specialists in the fields of strategic,developm...fices in Zurich,Bern and Geneva has published a ...rch Report, available in the "Investors" section o...
(Date:12/1/2008)...l disaster relief campaign , , WASHINGTON, ... Cross is asking people across the nation to help .... This holiday season push will put the final touc...ign for Disaster Relief. Already, the campaign has...tember, and the Red Cross hopes to meet its target...
(Date:12/1/2008)...-- Medication therapy management,(MTM) provider P...nals to its,advisory board. , New members ...y, M.D.;,Michael Burcham; and Kevin Hutchinson. ...s helped PharmMD launch and hone its MTM services,...suse, overuse and abuse. MTM is proven,to reduce...
Breaking Medicine News(10 mins):Health News:Mary Ann Liebert, Inc. Provides Free Online Journal Access in Recognition of World AIDS Day 2Health News:Red Cross Asks America to Help Raise $30 Million in 30 Days 2Health News:Red Cross Asks America to Help Raise $30 Million in 30 Days 3Health News:PharmMD Expands Advisory Board 2...ays and after many comfortable winter evenings, ma...arly// on their hips, thighs and buttocks. But on...panic, said Isabelle Keller of the German Society ...hen people return to their usual nutritional habit...
...latest report published in Archives of Otolaryngol...attributed// to psychiatric or neurologic conditio...n and women who had suffered dizziness for an exte...n the age group of 15 to 89. It was found that 339...
...ay be smiling. Researchers have given their opinio...sarian operations//, those decided solely upon by ...cording to their results published in the Canadian... encountered by a woman who opts for a C-section, ...
...ons has determined that by modifying a classic lig... as baseball players//, to their prior level of co...ial collateral ligament (MCL), which links and sta...rm where they meet at the elbow. Less traumatic ...
Other Medicine News:Health News:Permanent Weight Loss Requires Transition to Healthy Eating 2Health News:Modified Ligament Surgery Improves Outcomes Players, Athletes 2Health News:Modified Ligament Surgery Improves Outcomes Players, Athletes 3Holligard protects skin from irritating stomal discharge. Holligard is flexible and durable in heat and humidity.
Inquire
Inquire
Contour I pouches are light as a feather and feature our tapered SoftFlex skin barrier for comformability, flexbility and comfort. All Contour I pouches have ComfortWear panels that keep skin cool an
Medicine Products:| Copyright © 2003-2008 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |